Charles River Laboratories | CRL - Operating Expenses

Stock Price
201.41
Daily Change
-11.81 -5.54%
Monthly
-3.32%
Yearly
23.47%
Q1 Forecast
204.00

Charles River Laboratories reported $3.41B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Agilent USD 1.42B 57M Sep/2025
Align Technology USD 811.05M 38.37M Sep/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 776.6M 8.9M Sep/2025
Cardinal Health USD -2.88B 62.41B Sep/2025
Charles River Laboratories USD 3.41B 2.51B Sep/2025
Cigna USD 41.8B 23.4B Sep/2025
CVS Health USD 99.92B 4.3B Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 1.48B 653M Sep/2025
Elevance Health USD 49.17B 5.21B Dec/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Humana USD 32.25B 959M Sep/2025
Illumina USD 834M 20M Sep/2025
Incyte USD 4.65B 3.75B Sep/2025
IQVIA Holdings USD 6.16B 2.7B Sep/2025
Laboratory Of America USD 3.17B 101.7M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
McKesson USD 101.65B 4.91B Sep/2025
Merck EUR 4.11B 117M Sep/2025
Mettler Toledo International USD 735.5M 17.99M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 92.8B 82.47B Sep/2025
Quest Diagnostics USD 7.26B 4.94B Sep/2025
Revvity USD 600.61M 12.7M Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
United Therapeutics USD 6.59B 6.07B Sep/2025
UnitedHealth USD 109.96B 1.11B Dec/2025
Waters USD 2.33B 1.75B Sep/2025
West Pharmaceutical Services USD 3.05B 2.44B Sep/2025